Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT
Background: Postnatal corticosteroids are used to improve lung function and reduce the incidence of bronchopulmonary dysplasia (BPD) in preterm babies. However, corticosteroids may be associated with adverse neurodevelopment. Despite a lack of evidence, some clinicians in the UK use very low-dose re...
Main Authors: | Helen Yates, Virginia Chiocchia, Louise Linsell, Nicolas Orsi, Edmund Juszczak, Kathryn Johnson, Philip Chetcuti, Claire Illingworth, Pollyanna Hardy, Vaneesha Monk, Simon Newell, Mark Turner |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2019-08-01
|
Series: | Efficacy and Mechanism Evaluation |
Subjects: | |
Online Access: | https://doi.org/10.3310/eme06080 |
Similar Items
-
Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT
by: Yates, H, et al.
Published: (2019) -
Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia
by: Gina Lim, et al.
Published: (2015-08-01) -
Vitamin A Status in Preterm Infants Is Associated with Inflammation and Dexamethasone Exposure
by: Madelaine Eloranta Rossholt, et al.
Published: (2023-01-01) -
Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia
by: Heba Mohamed Al-taweel, et al.
Published: (2023-10-01) -
Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum
by: Juliann D. Jaumotte, et al.
Published: (2021-08-01)